Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
The truth is neutron scattering is not important, according to Steve Nagler. The knowledge gained from using it is what’s important
The U.S. Departments of Energy and Defense teamed up to create a series of weld filler materials that could dramatically improve high-strength steel repair in vehicles, bridges and pipelines.
Scientists at ORNL have created a miniaturized environment to study the ecosystem around poplar tree roots for insights into plant health and soil carbon sequestration.
ORNL researchers used the nation’s fastest supercomputer to map the molecular vibrations of an important but little-studied uranium compound produced during the nuclear fuel cycle for results that could lead to a cleaner, safer world.
A study led by researchers at ORNL could help make materials design as customizable as point-and-click.
A study by researchers at the ORNL takes a fresh look at what could become the first step toward a new generation of solar batteries.
Cement trucks entering and exiting the Spallation Neutron Source are a common sight as construction of the VENUS neutron imaging beamline progresses. Slated for completion and commissioning in 2024-2025, VENUS is the twentieth neutron instrument at SNS and will offer many new capabilities.
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.